Chemed Corporation (CHE)
NYSE: CHE · Real-Time Price · USD
569.05
-8.39 (-1.45%)
May 8, 2025, 4:00 PM - Market closed
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | NaN - NaN |
| VITAS | 1.58B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| VITAS Growth | 16.62% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Roto-Rooter | 904.63M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Roto-Rooter Growth | -3.24% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | NaN - NaN |
| VITAS Income From Operations | 273.62M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| VITAS Income From Operations Growth | 31.09% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Roto-Rooter Income From Operations | 192.88M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Roto-Rooter Income From Operations Growth | -10.92% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Income From Operations | -77.57M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Income From Operations Growth | -8.91% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBITDA by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | NaN - NaN |
| VITAS Adjusted EBITDA | 295.21M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| VITAS Adjusted EBITDA Growth | 28.82% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Roto-Rooter Adjusted EBITDA | 235.62M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Roto-Rooter Adjusted EBITDA Growth | -8.81% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Adjusted EBITDA | -20.76M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Adjusted EBITDA Growth | -1.75% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Net Income by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | NaN - NaN |
| VITAS Net Income | 222.88M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| VITAS Net Income Growth | 13.78% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Roto-Rooter Net Income | 159.14M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Roto-Rooter Net Income Growth | -2.23% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Net Income | -73.28M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Net Income Growth | -8.02% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | NaN - NaN |
| Total Average Daily Census (ADC) (Days) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Average Daily Census (ADC) (Days) Growth | 13.11% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Admissions | 68.68K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Admissions Growth | 7.26% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Discharges | 66.32K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Discharges Growth | 10.54% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Average Length of Stay (Days) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Average Length of Stay (Days) Growth | 14.24% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Median Length of Stay (Days) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Median Length of Stay (Days) Growth | 0% |
Log In |
Log In |
Log In |
Log In | Upgrade
|